Who Should Consider a Compounded GLP-1 Program - And Who Should Not A Compounded GLP-1 Program May Align With People Who: Are exploring prescription GLP-1 access without insurance coverage for brand-name options: If you do not have insurance that covers brand-name GLP-1 medications, self-pay compounded programs represent one pathway to prescription access
But I also believe in staying curious, following the science, and being willing to change my mind when the evidence demands it
She received advisory/consulting fees and/or other support from: Novo Nordisk, Eli Lilly and Company, Sanofi, AstraZeneca, Boehringer Ingelheim, Janssen, Intercept, Intarcia, Target Pharma, Merck, Pfizer, Novartis, GI Dynamics, Mylan, Mannkind, Valeritas, Zealand Pharma, Shionogi, Carmot and Bayer
You don't have to commit to anything today